The
American Society of Hematology sent their update today with their five
most-read articles:
- How I Treat In Brief: Managing
Monoclonal Gammopathy of Undetermined Significance
- Is Chronic Lymphocytic Leukemia
Curable With Newer Agents?
- FDA Approves Ibrutinib Combo for
Waldenström Macroglobulinemia
- Pulling Back the Curtain: Robert
Glassman, MD
- CMS Finalizes New CAR T-Cell
Payment Structure
They
also gave the option to follow them on Twitter… have you ever used Twitter? I
shall turn down that option…
No comments:
Post a Comment